EGFR mutations and high PD-L1 expression of lung squamous cell carcinoma patients achieving pCR following neoadjuvant immuno-chemotherapy: Case report

The treatment of lung cancer has fully entered the era of immunotherapy, which has significantly elevated the survival rate of patients with advanced non-small cell lung cancer (NSCLC), thus shedding light on resectable NSCLC. Previous clinical trial data suggested that neoadjuvant immuno-chemothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xiangyu, Shi, Zixia, Fu, Dan, Huang, Depei, Ma, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627657/
https://www.ncbi.nlm.nih.gov/pubmed/36338754
http://dx.doi.org/10.3389/fonc.2022.1008932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627657/
https://www.ncbi.nlm.nih.gov/pubmed/36338754
http://dx.doi.org/10.3389/fonc.2022.1008932

Ejemplares similares